These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 18323673

  • 1. A male case of nonclassical 21-hydroxylase deficiency first manifested in his sixties with adrenocortical incidentaloma.
    Nigawara T, Kageyama K, Sakihara S, Takayasu S, Kawahara M, Imai A, Ohyama C, Usui T, Sasano H, Suda T.
    Endocr J; 2008 May; 55(2):291-7. PubMed ID: 18323673
    [Abstract] [Full Text] [Related]

  • 2. Adrenal Tumor Mimicking Non-Classic Congenital Adrenal Hyperplasia.
    Tsai WH, Wong CH, Dai SH, Tsai CH, Zeng YH.
    Front Endocrinol (Lausanne); 2020 May; 11():526287. PubMed ID: 33117272
    [Abstract] [Full Text] [Related]

  • 3. Adrenocortical adenoma associated with inadequately treated congenital adrenal hyperplasia.
    Kurtoğlu S, Atabek ME, Keskin M, Patiroglu TE.
    J Pediatr Endocrinol Metab; 2003 Dec; 16(9):1311-4. PubMed ID: 14714757
    [Abstract] [Full Text] [Related]

  • 4. A 68-year-old phenotypically male patient with 21-hydroxylase deficiency and concomitant adrenocortical neoplasm producing testosterone and cortisol.
    Hayashi M, Kataoka Y, Sugimura Y, Kato F, Fukami M, Ogata T, Homma K, Hasegawa T, Oiso Y, Sasano H, Tanaka H.
    Tohoku J Exp Med; 2013 Oct; 231(2):75-84. PubMed ID: 24077358
    [Abstract] [Full Text] [Related]

  • 5. Adrenocortical incidentaloma with uncertain prognosis associated with an inadequately treated congenital adrenal hyperplasia.
    Chevalier N, Carrier P, Piche M, Chevallier A, Wagner K, Tardy V, Benchimol D, Fénichel P.
    Ann Endocrinol (Paris); 2010 Feb; 71(1):56-9. PubMed ID: 19942208
    [Abstract] [Full Text] [Related]

  • 6. Giant adrenal myelolipoma associated with 21-hydroxylase deficiency: unusual association mimicking an androgen-secreting adrenocortical carcinoma.
    Mermejo LM, Elias Junior J, Saggioro FP, Tucci Junior S, Castro Md, Moreira AC, Elias PC.
    Arq Bras Endocrinol Metabol; 2010 Jun; 54(4):419-24. PubMed ID: 20625655
    [Abstract] [Full Text] [Related]

  • 7. Late onset adrenal insufficiency after adrenalectomy due to latent nonclassical 21-hydroxylase deficiency: A case report.
    Hirai H, Kuwana K, Kusano Y.
    Medicine (Baltimore); 2018 Aug; 97(33):e11888. PubMed ID: 30113485
    [Abstract] [Full Text] [Related]

  • 8. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
    Seppel T, Schlaghecke R.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
    [Abstract] [Full Text] [Related]

  • 9. Lack of ACTH and androgen receptor expression in a giant adrenal myelolipoma associated with 21-hydroxylase deficiency.
    Hagiwara H, Usui T, Kimura T, Tagami T, Naruse M, Minamiguchi S, Kato T, Okuno H, Shimatsu A.
    Endocr Pathol; 2008 Oct; 19(2):122-7. PubMed ID: 18618087
    [Abstract] [Full Text] [Related]

  • 10. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB, Turatti W, Elias PC, Elias LL, Martinelli CE, Moreira AC, Antonini SR, de Castro M.
    Gene; 2013 Sep 10; 526(2):239-45. PubMed ID: 23570880
    [Abstract] [Full Text] [Related]

  • 11. Decreased levels of steroid 21-hydroxylase [P450(c21)] and its mRNA in an adrenocortical adenoma associated with 21-hydroxylase deficiency.
    Haji M, Ogo A, Ohashi M, Sekiya K, Takayanagi R, Takayama K, Kumazawa J, Nawata H.
    Endocrinol Jpn; 1990 Dec 10; 37(6):841-50. PubMed ID: 2101789
    [Abstract] [Full Text] [Related]

  • 12. Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors.
    Beuschlein F, Schulze E, Mora P, Gensheimer HP, Maser-Gluth C, Allolio B, Reincke M.
    J Clin Endocrinol Metab; 1998 Jul 10; 83(7):2585-8. PubMed ID: 9661649
    [Abstract] [Full Text] [Related]

  • 13. Cushing's syndrome by left adrenocortical adenoma synchronously associated with primary aldosteronism by right adrenocortical adenoma: report of a case.
    Onoda N, Ishikawa T, Nishio K, Tahara H, Inaba M, Wakasa K, Sumi T, Yamazaki T, Shigematsu K, Hirakawa K.
    Endocr J; 2009 Jul 10; 56(3):495-502. PubMed ID: 19270420
    [Abstract] [Full Text] [Related]

  • 14. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Bachega TA, Billerbeck AE, Marcondes JA, Madureira G, Arnhold IJ, Mendonca BB.
    Clin Endocrinol (Oxf); 2000 May 10; 52(5):601-7. PubMed ID: 10792340
    [Abstract] [Full Text] [Related]

  • 15. Incidental adreno-cortical adenoma, why surgery? a case report.
    Solís-López DR, Rodríguez-Hernández Z, Solís-López DH.
    P R Health Sci J; 2010 Jun 10; 29(2):130-2. PubMed ID: 20496530
    [Abstract] [Full Text] [Related]

  • 16. Pheochromocytoma and adrenocortical adenoma in the same gland.
    Hwang WR, Ma WY, Tso AL, Pan CC, Chang YH, Lin HD.
    J Chin Med Assoc; 2007 Jul 10; 70(7):289-93. PubMed ID: 17631466
    [Abstract] [Full Text] [Related]

  • 17. Adrenocortical tumor in a patient with untreated congenital adrenocortical hyperplasia owing to 21-hydroxylase deficiency: characterization of steroidogenic lesions.
    Takayama K, Ohashi M, Haji M, Matsumoto T, Mihara Y, Kumazawa J, Kato K.
    J Urol; 1988 Oct 10; 140(4):803-5. PubMed ID: 3418804
    [Abstract] [Full Text] [Related]

  • 18. The role of 21-hydroxylase in the pathogenesis of adrenal masses: review of the literature and focus on our own experience.
    Barzon L, Maffei P, Sonino N, Pilon C, Baldazzi L, Balsamo A, Del Maschio O, Masi G, Trevisan M, Pacenti M, Fallo F.
    J Endocrinol Invest; 2007 Oct 10; 30(7):615-23. PubMed ID: 17848847
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of adrenocortical tumor in a neonate by detection of elevated blood 17-hydroxyprogesterone measured as a routine neonatal screening for congenital adrenal hyperplasia: a case report.
    Hishiki T, Kazukawa I, Saito T, Terui K, Mitsunaga T, Nakata M, Matsuura G, Minagawa M, Kohno Y, Yoshida H.
    J Pediatr Surg; 2008 Oct 10; 43(10):e19-22. PubMed ID: 18926198
    [Abstract] [Full Text] [Related]

  • 20. Reassessment of predictive values of ACTH-stimulated serum 21-deoxycortisol and 17-hydroxyprogesterone to identify CYP21A2 heterozygote carriers and nonclassic subjects.
    Costa-Barbosa FA, Carvalho VM, Oliveira KC, Vieira JGH, Kater CE.
    Clin Endocrinol (Oxf); 2021 Oct 10; 95(4):677-685. PubMed ID: 34231242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.